Fluxapyroxad Patent Landscape Analysis

Fluxapyroxad is an SDHI fungicide developed by BASF, commercialised through the Xemium® brand.

The retained landscape covers 360 patent families across 144 consolidated owner groups. Two-active combination is the thickest protection layer (225 families), with single-active formulation providing additional constraint.

190 of the 360 retained families carry a grant or national pending reading. 161 families are held by China-based applicants; 29 live families have a nominal term ending within five years. Position as at October 2026.

This 97-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.